This pooled analysis of two prospective observational registry studies evaluated the long-term effects of testosterone undecanoate therapy in 156 obese hypogonadal men with type 2 diabetes mellitus (T2DM) over a period of up to 6 years. Testosterone treatment led to significant and sustained reductions in weight (mean loss of 17.49